Surface Oncology, Inc.
SURF · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28,192 | -$19,741 | -$21,332 | -$23,240 |
| Dep. & Amort. | $1,989 | $318 | $331 | $346 |
| Deferred Tax | -$109 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,186 | $1,646 | $1,519 | $1,766 |
| Change in WC | $1,725 | -$6,267 | -$2,854 | $1,596 |
| Other Non-Cash | $3,840 | $605 | $582 | $705 |
| Operating Cash Flow | -$19,561 | -$23,439 | -$21,754 | -$18,827 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $17 | -$17 | -$292 | -$59 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,638 | -$16,930 | -$9,883 | -$14,618 |
| Inv. Sales/Matur. | $50,720 | $18,350 | $17,700 | $15,000 |
| Other Inv. Act. | -$28 | $31 | $0 | $0 |
| Investing Cash Flow | $32,071 | $1,434 | $7,525 | $323 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $44 | $8,666 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$28,245 | $77 | $43 | $8,776 |
| Financing Cash Flow | -$28,245 | $77 | $43 | $8,776 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15,735 | -$21,928 | -$14,186 | -$9,728 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,577 | $52,505 | $66,691 | $76,419 |
| End Cash | $14,842 | $30,577 | $52,505 | $66,691 |
| Free Cash Flow | -$19,544 | -$23,456 | -$22,046 | -$18,886 |